Deep Dive Into Procter & Gamble Stock: Analyst Perspectives (7 Ratings)
Procter & Gamble Company PG | 143.12 | -0.67% |
Procter & Gamble (NYSE:PG) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 2 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $162.14, a high estimate of $179.00, and a low estimate of $150.00. This current average has decreased by 1.73% from the previous average price target of $165.00.

Exploring Analyst Ratings: An In-Depth Overview
An in-depth analysis of recent analyst actions unveils how financial experts perceive Procter & Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Andrea Teixeira | JP Morgan | Raises | Overweight | $165.00 | $157.00 |
| Peter Grom | UBS | Lowers | Buy | $161.00 | $176.00 |
| Robert Moskow | TD Cowen | Lowers | Buy | $150.00 | $168.00 |
| Chris Carey | Wells Fargo | Lowers | Overweight | $158.00 | $170.00 |
| Andrea Teixeira | JP Morgan | Lowers | Neutral | $157.00 | $165.00 |
| Kaumil Gajrawala | Jefferies | Raises | Buy | $179.00 | $156.00 |
| Andrea Teixeira | JP Morgan | Raises | Neutral | $165.00 | $163.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Procter & Gamble. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Procter & Gamble compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Procter & Gamble's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into Procter & Gamble's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Procter & Gamble analyst ratings.
Unveiling the Story Behind Procter & Gamble
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
Breaking Down Procter & Gamble's Financial Performance
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining Procter & Gamble's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.99% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Procter & Gamble's net margin is impressive, surpassing industry averages. With a net margin of 20.89%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 9.02%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Procter & Gamble's ROA stands out, surpassing industry averages. With an impressive ROA of 3.7%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Procter & Gamble's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.68.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
